Clinical Fellow/Senior Clinical Fellow

Increased number of novel therapeutic agents and the progressively greater complexity of early clinical trials have led to a need for more physicians with special skills in drug development. The major objective of the ADTTP is to provide medical oncologists advanced training in state-of-the-science principles and technologies of developmental therapeutics by utilizing the unique resources available within the National Cancer Institute (NCI). The successful candidate(s) will participate in clinical research conducted at the NIH Clinical Center in Bethesda, MD, Developmental Therapeutics Clinic (DTC) (https://dtc.cancer.gov/), NCI. The program will provide an excellent opportunity to refine skills in clinical investigation including novel strategies for trial design and methodology, protocol development, execution, monitoring, conformity with ethical standards, and formulation of attainable and pertinent laboratory correlates. The trainee(s) will spend 40-60 percent of effort in clinical investigation involving inpatients and outpatients at the NIH, including a minimum of 1.5 days in DTC clinic activities. In addition, the trainee(s) will spend up to 40 percent effort in the DCTD Cancer Therapy Evaluation Program (CTEP) (https://ctep.cancer.gov/). The CTEP component of the training will broaden the trainee’s knowledge of new drug development by providing a unique opportunity to learn principles and concepts of agent prioritization, drug development strategies, protocol development and review, IND requirements, adverse event assessment and reporting. Candidates must meet all of the following requirements:

• M.D. or an equivalent degree with a license to practice medicine in the United States
• Completion of subspecialty training in Medical Oncology at a US-accredited institution
• Board certification or eligibility in Medical Oncology A full federal package of benefits (including retirement, leave, health, life, and a 401K equivalent savings plan, etc.) is available. This is a time-limited federal appointment not-to-exceed 2-3 years (there is no assurance of a tenure-track or permanent position with NIH upon completion of the program). Salary is commensurate with experience.

HHS, NIH AND NCI ARE EQUAL OPPORTUNITY EMPLOYERS

Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization. The NIH encourages the application and nomination of qualified women, minorities, and individuals with disabilities.